The Novartis Group is one of the biggest global pharmaceutical and healthcare groups. It provides solutions to address the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs. The Complainant, Novartis AG, was created in 1996 through a merger of two other companies Ciba-Geigy and Sandoz, and it is the holding company of the Novartis Group.
The Complainant has an active presence in Nigeria where the Respondent is located, dated back to 2004 and has been active since then, inter alia with scientific programs against Malaria.
The Complainant owns numerous domain names composed of either its trademark NOVARTIS alone, including <novartis.com>, <novartis.net> or in combination with other terms, e.g. <novartispharma.com>.
The disputed domain name <novartix.org> was registered on October 17, 2021 and has been used in connection to an active website, mirroring the Novartis UK website.
According to the Response, the Respondent is a freelance Web Developer, who was hired to create the website under the disputed domain name.
|